首页 > 最新文献

Neuroradiology Journal最新文献

英文 中文
Treatment outcome of bridge mechanical thrombectomy with different IV-tPA dosages in the standard and extended time window in real-world practice. 在实际操作中,在标准时间窗和延长时间窗内使用不同剂量的 IV-tPA 进行桥式机械血栓切除术的治疗效果。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-26 DOI: 10.1177/19714009241269447
Hao-Te Liu, Wen-Chun Deng, Ching-Wen Chang, Yi Ming Wu, Ho-Fai Wong, Chien-Hung Chang, Mun-Chun Yeap, Ching-Chang Chen, Chung-Ting Chen, Yu-Ting Huang, Yao-Liang Chen

Background: Differences of treatment outcome between full or reduced dose of tissue plasminogen activator (tPA) for bridge mechanical thrombectomy (MT) in the extended time window have not been clearly established. We aimed to present real-world results of bridge MT with different tPA dosages in the standard and extended windows.

Materials and methods: Patients with anterior circulation stroke treated with MT between 2017 and 2021 at two stroke referral centers were retrospectively reviewed. Bridge MT with tPA were categorized as full (0.9 mg/kg) or reduced (<0.9 mg/kg) dose. Standard window (SW) cohort was defined as MT performed within 6 h of acute ischemic stroke onset, while those beyond 6 h as the extended window (EW) cohort. 90 days Modified Rankin Scale (mRS) score, technical treatment success, in-hospital mortality, and post-treatment hemorrhage were analyzed.

Results: A total of 423 patients met the inclusion criteria, 218 of which treated in the SW, while 205 treated in the EW. Within the SW cohort, the full-dose tPA group demonstrated a higher proportion of good functional outcome (GFO) at 90 days (mRS0-3) versus reduced (49% vs 21%, p = 0.0358). The overall GFO of SW was higher than that of the EW cohort (33% vs 20%, p = 0.0480). Within the EW cohort, GFO was similar between full and reduced dose groups. Successful reperfusion rate was lower in SW versus EW cohorts (39% vs 58%, p = 0.0199).

Conclusion: In real-world practice, the GFO of bridge MT is better than MT alone. The tPA dosage is not a determining factor of GFO in EW MT.

背景:在延长时间窗内使用全剂量或低剂量组织血浆酶原激活剂(tPA)进行桥接机械血栓切除术(MT)的治疗效果差异尚未明确确定。我们旨在介绍在标准时间窗和延长时间窗使用不同剂量 tPA 进行桥接机械取栓术的实际结果:回顾性研究了2017年至2021年间在两家卒中转诊中心接受MT治疗的前循环卒中患者。使用tPA的桥接MT分为全量(0.9 mg/kg)和减量(Results:共有 423 例患者符合纳入标准,其中 218 例在 SW 治疗,205 例在 EW 治疗。在 SW 组群中,全剂量 tPA 组 90 天后(mRS0-3)的良好功能预后(GFO)比例高于减量组(49% 对 21%,P = 0.0358)。SW组的总体GFO高于EW组(33% vs 20%,p = 0.0480)。在 EW 组群中,全剂量组和减量组的 GFO 相似。SW组的再灌注成功率低于EW组(39% vs 58%,P = 0.0199):结论:在实际应用中,桥接 MT 的 GFO 优于单用 MT。结论:在实际应用中,桥接 MT 的 GFO 优于单纯 MT,tPA 剂量不是 EW MT GFO 的决定因素。
{"title":"Treatment outcome of bridge mechanical thrombectomy with different IV-tPA dosages in the standard and extended time window in real-world practice.","authors":"Hao-Te Liu, Wen-Chun Deng, Ching-Wen Chang, Yi Ming Wu, Ho-Fai Wong, Chien-Hung Chang, Mun-Chun Yeap, Ching-Chang Chen, Chung-Ting Chen, Yu-Ting Huang, Yao-Liang Chen","doi":"10.1177/19714009241269447","DOIUrl":"10.1177/19714009241269447","url":null,"abstract":"<p><strong>Background: </strong>Differences of treatment outcome between full or reduced dose of tissue plasminogen activator (tPA) for bridge mechanical thrombectomy (MT) in the extended time window have not been clearly established. We aimed to present real-world results of bridge MT with different tPA dosages in the standard and extended windows.</p><p><strong>Materials and methods: </strong>Patients with anterior circulation stroke treated with MT between 2017 and 2021 at two stroke referral centers were retrospectively reviewed. Bridge MT with tPA were categorized as full (0.9 mg/kg) or reduced (<0.9 mg/kg) dose. Standard window (SW) cohort was defined as MT performed within 6 h of acute ischemic stroke onset, while those beyond 6 h as the extended window (EW) cohort. 90 days Modified Rankin Scale (mRS) score, technical treatment success, in-hospital mortality, and post-treatment hemorrhage were analyzed.</p><p><strong>Results: </strong>A total of 423 patients met the inclusion criteria, 218 of which treated in the SW, while 205 treated in the EW. Within the SW cohort, the full-dose tPA group demonstrated a higher proportion of good functional outcome (GFO) at 90 days (mRS0-3) versus reduced (49% vs 21%, <i>p</i> = 0.0358). The overall GFO of SW was higher than that of the EW cohort (33% vs 20%, <i>p</i> = 0.0480). Within the EW cohort, GFO was similar between full and reduced dose groups. Successful reperfusion rate was lower in SW versus EW cohorts (39% vs 58%, <i>p</i> = 0.0199).</p><p><strong>Conclusion: </strong>In real-world practice, the GFO of bridge MT is better than MT alone. The tPA dosage is not a determining factor of GFO in EW MT.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"19714009241269447"},"PeriodicalIF":1.3,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142056895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing a rapid cord compression Magnetic Resonance Imaging protocol in the emergency department: Lessons learned. 在急诊科实施快速脊髓压迫磁共振成像方案:经验教训。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-08 DOI: 10.1177/19714009241269540
Shruti Mishra, Ashok Srinivasan, Lauren Kelsey, Katherine Bojicic, Maria Masotti, Qiaochu Chen, Ellen Hoeffner, Steven Kronick, Diana Gomez-Hassan

Background & purpose: (1) Evaluate efficacy of an abbreviated total spine protocol in triaging emergency department (ED) patients through retrospective evaluation. (2) Describe patient outcomes following implementation of a rapid cord compression protocol.

Methods: (1) All contrast-enhanced total spine magnetic resonance imaging studies (MRIs) performed on ED patients (n = 75) between 10/1-12/31/2022 for evaluation of cord compression were included. Two readers with 6 and 5 years of experience blindly reviewed the abbreviated protocol (comprised of sagittal T2w and axial T2w sequences) assessing presence of cord compression or severe spinal canal stenosis. Ground truth was consensus by a neuroradiology fellow and 2 attendings. (2) The implemented rapid protocol included sagittal T1w, sagittal T2w Dixon and axial T2w images. All ED patients (n = 85) who were imaged using the rapid protocol from 5/1-8/31/2023 were included. Patient outcomes and call-back rates were determined through chart review.

Results: (1) Sensitivity and specificity for severe spinal canal stenosis and/or cord compression was 1.0 and 0.92, respectively, for reader 1 and 0.78 and 0.85, respectively, for reader 2. Negative predictive value was 1.0 and 0.97 for readers 1 and 2, respectively. (2) The implemented rapid cord compression protocol resulted in 60% reduction in imaging time at 1.5T. The call-back rate for additional sequences was 7%. In patients who underwent surgery, no additional MRI images were acquired in 82% of cases (9/11).

Conclusions: Implementing an abbreviated non-contrast total spine protocol in the ED results in a low call-back rate with acquired MRI images proving sufficient for both triage and treatment planning in most patients.

背景和目的:(1)通过回顾性评估,评价简略全脊柱方案在急诊科(ED)患者分流中的疗效。(方法:(1)纳入 2022 年 10 月 1 日至 12 月 31 日期间为评估脊髓压迫而对急诊科患者(n = 75)进行的所有对比增强全脊柱磁共振成像(MRI)检查。两名分别有 6 年和 5 年经验的读片员对简略方案(包括矢状面 T2w 和轴向 T2w 序列)进行盲审,评估是否存在脊髓压迫或严重的椎管狭窄。一名神经放射学研究员和两名主治医师就基本事实达成共识。(2)实施的快速方案包括矢状位 T1w、矢状位 T2w Dixon 和轴位 T2w 图像。所有在 2023 年 5 月 1 日至 8 月 31 日期间使用快速方案成像的急诊室患者(n = 85)均被纳入其中。结果:(1) 对严重椎管狭窄和/或脊髓压迫的敏感性和特异性,阅读器 1 分别为 1.0 和 0.92,阅读器 2 分别为 0.78 和 0.85。读者 1 和读者 2 的阴性预测值分别为 1.0 和 0.97。(2)实施快速脐带压缩方案后,1.5T 的成像时间缩短了 60%。额外序列的回调率为 7%。在接受手术的患者中,82%的病例(9/11)无需获取额外的磁共振成像:结论:在急诊室实施简短的非对比全脊柱方案可降低回访率,所获得的 MRI 图像足以满足大多数患者的分诊和治疗计划。
{"title":"Implementing a rapid cord compression Magnetic Resonance Imaging protocol in the emergency department: Lessons learned.","authors":"Shruti Mishra, Ashok Srinivasan, Lauren Kelsey, Katherine Bojicic, Maria Masotti, Qiaochu Chen, Ellen Hoeffner, Steven Kronick, Diana Gomez-Hassan","doi":"10.1177/19714009241269540","DOIUrl":"10.1177/19714009241269540","url":null,"abstract":"<p><strong>Background & purpose: </strong>(1) Evaluate efficacy of an abbreviated total spine protocol in triaging emergency department (ED) patients through retrospective evaluation. (2) Describe patient outcomes following implementation of a rapid cord compression protocol.</p><p><strong>Methods: </strong>(1) All contrast-enhanced total spine magnetic resonance imaging studies (MRIs) performed on ED patients (<i>n</i> = 75) between 10/1-12/31/2022 for evaluation of cord compression were included. Two readers with 6 and 5 years of experience blindly reviewed the abbreviated protocol (comprised of sagittal T2w and axial T2w sequences) assessing presence of cord compression or severe spinal canal stenosis. Ground truth was consensus by a neuroradiology fellow and 2 attendings. (2) The implemented rapid protocol included sagittal T1w, sagittal T2w Dixon and axial T2w images. All ED patients (<i>n</i> = 85) who were imaged using the rapid protocol from 5/1-8/31/2023 were included. Patient outcomes and call-back rates were determined through chart review.</p><p><strong>Results: </strong>(1) Sensitivity and specificity for severe spinal canal stenosis and/or cord compression was 1.0 and 0.92, respectively, for reader 1 and 0.78 and 0.85, respectively, for reader 2. Negative predictive value was 1.0 and 0.97 for readers 1 and 2, respectively. (2) The implemented rapid cord compression protocol resulted in 60% reduction in imaging time at 1.5T. The call-back rate for additional sequences was 7%. In patients who underwent surgery, no additional MRI images were acquired in 82% of cases (9/11).</p><p><strong>Conclusions: </strong>Implementing an abbreviated non-contrast total spine protocol in the ED results in a low call-back rate with acquired MRI images proving sufficient for both triage and treatment planning in most patients.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"19714009241269540"},"PeriodicalIF":1.3,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571330/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Genetic tumor syndromes of the head and neck: Update in the genomic era". "头颈部遗传性肿瘤综合征:基因组时代的更新"。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-07 DOI: 10.1177/19714009241269462
Sneh Brahmbhatt, Amit Agarwal, Dhruv Shetty, Amit Desai, Alok A Bhatt

Genetic tumor syndromes are due to inherited genetic mutations, which have recently come to the attention of clinicians due to the widespread adoption of DNA sequencing, ultimately leading to imaging for surveillance. As a result, radiologists must be familiar with the clinical, genetic, and radiologic features of these syndromes. This article reviews genetic tumor syndromes of the head and neck according to the recently updated WHO's 5th edition.

遗传性肿瘤综合征是由遗传性基因突变引起的,最近由于 DNA 测序的广泛应用而引起临床医生的注意,最终导致影像学监测。因此,放射科医生必须熟悉这些综合征的临床、遗传和放射学特征。本文根据最近更新的世界卫生组织第五版对头颈部遗传性肿瘤综合征进行了综述。
{"title":"\"Genetic tumor syndromes of the head and neck: Update in the genomic era\".","authors":"Sneh Brahmbhatt, Amit Agarwal, Dhruv Shetty, Amit Desai, Alok A Bhatt","doi":"10.1177/19714009241269462","DOIUrl":"10.1177/19714009241269462","url":null,"abstract":"<p><p>Genetic tumor syndromes are due to inherited genetic mutations, which have recently come to the attention of clinicians due to the widespread adoption of DNA sequencing, ultimately leading to imaging for surveillance. As a result, radiologists must be familiar with the clinical, genetic, and radiologic features of these syndromes. This article reviews genetic tumor syndromes of the head and neck according to the recently updated WHO's 5th edition.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"19714009241269462"},"PeriodicalIF":1.3,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141903161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Soft tissue aneurysmal bone cyst presenting as an enlarging neck mass: Case report and review of the head and neck literature. 软组织动脉瘤性骨囊肿表现为颈部肿块增大:病例报告和头颈部文献综述。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-06 DOI: 10.1177/19714009241269441
Stephen A Chan, John C Benson, Michelle A Neben Wittich, Kyriakos Chatzopoulos, Joaquin J Garcia, Katherine B Geiersbach, Lucinda M Gruber, Robert A Wermers, Robert J Pignolo, Peter S Rose, Kathryn M Van Abel

Soft tissue aneurysmal bone cysts (STABCs) are rare neoplasms histopathologically identical to aneurysmal bone cysts. These benign lesions are characterized by thin, peripheral ossification and no skeletal continuity. STABC may be difficult to distinguish from myositis ossificans (MO) and malignant entities from imaging and fine needle aspiration, due to rarity and overlapping features. We present a case of a STABC occurring in the paraspinal cervical muscles. The imaging, histopathology, molecular analysis, and treatment are discussed. Four other published cases of STABC of the head and neck are reviewed.

软组织动脉瘤性骨囊肿(STABC)是一种罕见的肿瘤,在组织病理学上与动脉瘤性骨囊肿相同。这些良性病变的特点是外周骨化薄且无骨骼连续性。由于罕见和特征重叠,STABC 可能很难从影像学和细针穿刺中与骨化性肌炎(MO)和恶性肿瘤区分开来。我们介绍了一例发生在颈椎旁肌肉的 STABC。本文讨论了影像学、组织病理学、分子分析和治疗方法。本文还回顾了其他四例已发表的头颈部STABC病例。
{"title":"Soft tissue aneurysmal bone cyst presenting as an enlarging neck mass: Case report and review of the head and neck literature.","authors":"Stephen A Chan, John C Benson, Michelle A Neben Wittich, Kyriakos Chatzopoulos, Joaquin J Garcia, Katherine B Geiersbach, Lucinda M Gruber, Robert A Wermers, Robert J Pignolo, Peter S Rose, Kathryn M Van Abel","doi":"10.1177/19714009241269441","DOIUrl":"10.1177/19714009241269441","url":null,"abstract":"<p><p>Soft tissue aneurysmal bone cysts (STABCs) are rare neoplasms histopathologically identical to aneurysmal bone cysts. These benign lesions are characterized by thin, peripheral ossification and no skeletal continuity. STABC may be difficult to distinguish from myositis ossificans (MO) and malignant entities from imaging and fine needle aspiration, due to rarity and overlapping features. We present a case of a STABC occurring in the paraspinal cervical muscles. The imaging, histopathology, molecular analysis, and treatment are discussed. Four other published cases of STABC of the head and neck are reviewed.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"19714009241269441"},"PeriodicalIF":1.3,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting telomerase reverse transcriptase promoter mutation in glioma: A systematic review and diagnostic meta-analysis on machine learning algorithms. 预测胶质瘤端粒酶逆转录酶启动子突变:关于机器学习算法的系统综述和诊断荟萃分析。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-05 DOI: 10.1177/19714009241269526
Mohammad Amin Habibi, Ali Dinpazhouh, Aliakbar Aliasgary, Mohammad Sina Mirjani, Mehdi Mousavinasab, Mohammad Reza Ahmadi, Poriya Minaee, SeyedMohammad Eazi, Milad Shafizadeh, Muhammet Enes Gurses, Victor M Lu, Chandler N Berke, Michael E Ivan, Ricardo J Komotar, Ashish H Shah

Background: Glioma is one of the most common primary brain tumors. The presence of the telomerase reverse transcriptase promoter (pTERT) mutation is associated with a better prognosis. This study aims to investigate the TERT mutation in patients with glioma using machine learning (ML) algorithms on radiographic imaging.

Method: This study was prepared according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The electronic databases of PubMed, Embase, Scopus, and Web of Science were searched from inception to August 1, 2023. The statistical analysis was performed using the MIDAS package of STATA v.17.

Results: A total of 22 studies involving 5371 patients were included for data extraction, with data synthesis based on 11 reports. The analysis revealed a pooled sensitivity of 0.86 (95% CI: 0.78-0.92) and a specificity of 0.80 (95% CI 0.72-0.86). The positive and negative likelihood ratios were 4.23 (95% CI: 2.99-5.99) and 0.18 (95% CI: 0.11-0.29), respectively. The pooled diagnostic score was 3.18 (95% CI: 2.45-3.91), with a diagnostic odds ratio 24.08 (95% CI: 11.63-49.87). The Summary Receiver Operating Characteristic (SROC) curve had an area under the curve (AUC) of 0.89 (95% CI: 0.86-0.91).

Conclusion: The study suggests that ML can predict TERT mutation status in glioma patients. ML models showed high sensitivity (0.86) and moderate specificity (0.80), aiding disease prognosis and treatment planning. However, further development and improvement of ML models are necessary for better performance metrics and increased reliability in clinical practice.

背景:胶质瘤是最常见的原发性脑肿瘤之一:胶质瘤是最常见的原发性脑肿瘤之一。端粒酶逆转录酶启动子(pTERT)突变与较好的预后有关。本研究旨在利用机器学习(ML)算法对神经胶质瘤患者的放射成像进行TERT突变研究:本研究根据《系统综述和元分析首选报告项目》(Preferred Reporting Items for Systematic Reviews and Meta-Analyses,PRISMA)指南进行准备。检索了从开始到 2023 年 8 月 1 日的 PubMed、Embase、Scopus 和 Web of Science 等电子数据库。统计分析使用 STATA v.17 的 MIDAS 软件包进行:共纳入了 22 项研究,涉及 5371 名患者的数据提取,并根据 11 份报告进行了数据综合。分析结果显示,汇总灵敏度为 0.86(95% CI:0.78-0.92),特异度为 0.80(95% CI:0.72-0.86)。阳性和阴性似然比分别为 4.23(95% CI:2.99-5.99)和 0.18(95% CI:0.11-0.29)。汇总诊断得分为 3.18(95% CI:2.45-3.91),诊断几率比为 24.08(95% CI:11.63-49.87)。总结接收者操作特征曲线(SROC)的曲线下面积(AUC)为 0.89(95% CI:0.86-0.91):研究表明,ML 可以预测胶质瘤患者的 TERT 突变状态。ML模型显示出较高的灵敏度(0.86)和中等程度的特异性(0.80),有助于疾病预后和治疗计划的制定。然而,为了在临床实践中获得更好的性能指标和更高的可靠性,有必要进一步开发和改进 ML 模型。
{"title":"Predicting telomerase reverse transcriptase promoter mutation in glioma: A systematic review and diagnostic meta-analysis on machine learning algorithms.","authors":"Mohammad Amin Habibi, Ali Dinpazhouh, Aliakbar Aliasgary, Mohammad Sina Mirjani, Mehdi Mousavinasab, Mohammad Reza Ahmadi, Poriya Minaee, SeyedMohammad Eazi, Milad Shafizadeh, Muhammet Enes Gurses, Victor M Lu, Chandler N Berke, Michael E Ivan, Ricardo J Komotar, Ashish H Shah","doi":"10.1177/19714009241269526","DOIUrl":"10.1177/19714009241269526","url":null,"abstract":"<p><strong>Background: </strong>Glioma is one of the most common primary brain tumors. The presence of the telomerase reverse transcriptase promoter (pTERT) mutation is associated with a better prognosis. This study aims to investigate the TERT mutation in patients with glioma using machine learning (ML) algorithms on radiographic imaging.</p><p><strong>Method: </strong>This study was prepared according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The electronic databases of PubMed, Embase, Scopus, and Web of Science were searched from inception to August 1, 2023. The statistical analysis was performed using the MIDAS package of STATA v.17.</p><p><strong>Results: </strong>A total of 22 studies involving 5371 patients were included for data extraction, with data synthesis based on 11 reports. The analysis revealed a pooled sensitivity of 0.86 (95% CI: 0.78-0.92) and a specificity of 0.80 (95% CI 0.72-0.86). The positive and negative likelihood ratios were 4.23 (95% CI: 2.99-5.99) and 0.18 (95% CI: 0.11-0.29), respectively. The pooled diagnostic score was 3.18 (95% CI: 2.45-3.91), with a diagnostic odds ratio 24.08 (95% CI: 11.63-49.87). The Summary Receiver Operating Characteristic (SROC) curve had an area under the curve (AUC) of 0.89 (95% CI: 0.86-0.91).</p><p><strong>Conclusion: </strong>The study suggests that ML can predict TERT mutation status in glioma patients. ML models showed high sensitivity (0.86) and moderate specificity (0.80), aiding disease prognosis and treatment planning. However, further development and improvement of ML models are necessary for better performance metrics and increased reliability in clinical practice.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"19714009241269526"},"PeriodicalIF":1.3,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of flow redirection endoluminal device (FRED) for treatment of intracranial aneurysm; A systematic review and meta-analysis. 用于治疗颅内动脉瘤的血流重定向腔内装置(FRED)的安全性和有效性;系统回顾和荟萃分析。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-05 DOI: 10.1177/19714009241269460
Mohammad Amin Habibi, Mohammad Sina Mirjani, Amir Mahmoud Ahmadzadeh, Mohammad Taha Akbari Javar, Shaghayegh Karami, Muhammad Hussain Ahmadvand

Background: Previous research has shown promising results for treating intracranial aneurysms (IAs) with a flow redirection endoluminal device (FRED). In this systematic review and meta-analysis, we aimed to assess the safety and efficacy of this device by providing pooled estimates using the data from previous studies.

Methods: A systematic literature search of Web of Sciences, PubMed, Scopus, and Embase was performed until October 8th, 2023. After selecting the final articles, relevant data were extracted. Parameters relating to safety and efficacy were pooled using STATA software. Heterogeneity was assessed using I-squared and Cochran's Q. Funnel plots and Egger's regression methods were used to evaluate publication bias. Sensitivity analysis was also performed using the leave-one-out method.

Results: The data of 37 studies were used for meta-analysis. The rates of immediate adequate occlusion and complete occlusion were 0.51 (95% CI: 0.31-0.71) and 0.34 (95% CI: 0.16-0.53), respectively, while the rates of the adequate and complete occlusion at the latest follow-up were 0.90 (95% CI: 0.84-0.94) and 0.75 (95% CI: 0.65-0.84), respectively. The periprocedural complications rate was 0.04 (95% CI: 0.03-0.06), and the overall complications rate was 0.12 (95% CI: 0.09-0.15). The rate of good functional outcome was 0.99 (95% CI: 0.99-1.00) and the successful implantation rate was 1.00 (95% CI: 1.00-1.00). There was substantial heterogeneity among the reports for most of the evaluated parameters.

Conclusion: FRED had high safety and efficacy in treating IAs, as evidenced by its high occlusion and low complication rates.

背景:以往的研究表明,使用血流重定向腔内装置(FRED)治疗颅内动脉瘤(IAs)效果良好。在这篇系统性综述和荟萃分析中,我们旨在利用以往研究的数据提供汇总估计值,从而评估该装置的安全性和有效性:截至 2023 年 10 月 8 日,我们对 Web of Sciences、PubMed、Scopus 和 Embase 进行了系统的文献检索。在筛选出最终文章后,提取了相关数据。使用 STATA 软件对安全性和有效性相关参数进行汇总。使用漏斗图和 Egger 回归法评估发表偏倚。此外,还使用 "留一剔除 "法进行了敏感性分析:结果:37 项研究的数据被用于荟萃分析。即刻充分闭塞率和完全闭塞率分别为 0.51(95% CI:0.31-0.71)和 0.34(95% CI:0.16-0.53),而最近一次随访时的充分闭塞率和完全闭塞率分别为 0.90(95% CI:0.84-0.94)和 0.75(95% CI:0.65-0.84)。围手术期并发症发生率为0.04(95% CI:0.03-0.06),总体并发症发生率为0.12(95% CI:0.09-0.15)。功能良好率为 0.99(95% CI:0.99-1.00),成功植入率为 1.00(95% CI:1.00-1.00)。就大多数评估参数而言,各报告之间存在很大的异质性:结论:FRED在治疗IAs方面具有很高的安全性和有效性,其高闭塞率和低并发症发生率证明了这一点。
{"title":"Safety and efficacy of flow redirection endoluminal device (FRED) for treatment of intracranial aneurysm; A systematic review and meta-analysis.","authors":"Mohammad Amin Habibi, Mohammad Sina Mirjani, Amir Mahmoud Ahmadzadeh, Mohammad Taha Akbari Javar, Shaghayegh Karami, Muhammad Hussain Ahmadvand","doi":"10.1177/19714009241269460","DOIUrl":"10.1177/19714009241269460","url":null,"abstract":"<p><strong>Background: </strong>Previous research has shown promising results for treating intracranial aneurysms (IAs) with a flow redirection endoluminal device (FRED). In this systematic review and meta-analysis, we aimed to assess the safety and efficacy of this device by providing pooled estimates using the data from previous studies.</p><p><strong>Methods: </strong>A systematic literature search of Web of Sciences, PubMed, Scopus, and Embase was performed until October 8th, 2023. After selecting the final articles, relevant data were extracted. Parameters relating to safety and efficacy were pooled using STATA software. Heterogeneity was assessed using I-squared and Cochran's Q. Funnel plots and Egger's regression methods were used to evaluate publication bias. Sensitivity analysis was also performed using the leave-one-out method.</p><p><strong>Results: </strong>The data of 37 studies were used for meta-analysis. The rates of immediate adequate occlusion and complete occlusion were 0.51 (95% CI: 0.31-0.71) and 0.34 (95% CI: 0.16-0.53), respectively, while the rates of the adequate and complete occlusion at the latest follow-up were 0.90 (95% CI: 0.84-0.94) and 0.75 (95% CI: 0.65-0.84), respectively. The periprocedural complications rate was 0.04 (95% CI: 0.03-0.06), and the overall complications rate was 0.12 (95% CI: 0.09-0.15). The rate of good functional outcome was 0.99 (95% CI: 0.99-1.00) and the successful implantation rate was 1.00 (95% CI: 1.00-1.00). There was substantial heterogeneity among the reports for most of the evaluated parameters.</p><p><strong>Conclusion: </strong>FRED had high safety and efficacy in treating IAs, as evidenced by its high occlusion and low complication rates.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"19714009241269460"},"PeriodicalIF":1.3,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571416/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of basilar artery aneurysms with two braided stents: Two centers experience of low-profile visualized intraluminal support stents versus Pipeline flow diverters. 用双编织支架治疗基底动脉瘤:两个中心的低调可视腔内支撑支架与管道导流器的对比经验。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-01 Epub Date: 2024-03-28 DOI: 10.1177/19714009241242638
Bin Luo, Chao Wang, Jian Liu, Yisen Zhang, Kun Wang, Wenqiang Li, Ying Zhang

Background: Both low-profile visualized intraluminal support (LVIS)stents and Pipeline flow diverters (FDs) are therapeutic strategies for basilar artery (BA) aneurysms, but they have not been directly compared.

Methods: A total of 132 consecutive patients with 139 BA aneurysms treated with either LVIS stent or Pipeline FDs were analyzed. Propensity score matching (PSM) was used to control for age, sex, hypertension, aneurysm size, shape, location, and duration of follow-up. The treatment results of these two braided stents were compared.

Results: LVIS stent was placed in 88 (63.3%) and Pipeline FDs in 51 (36.7%) procedures. Patients with Pipeline FDs tended to be younger and have less hypertension, whereas aneurysms had larger aneurysm size. After PSM, similar complete or near-complete occlusion rates (76.7% vs 73.3%, p = .766) and favorable functional outcomes (86.7% vs 90.0%, p = 1) were achieved in patients treated with LVIS stents and Pipeline FDs, respectively. Further comparisons were conducted at three different locations (basilar apex/basilar trunk/vertebrobasilar artery junction [VBJ]) separately, and the results showed a higher complete or near-complete aneurysm occlusion rate after Pipeline FD treatment than LVIS treatment (86.7% vs 59.2%, p = .012) only at VBJ, where a particularly high proportion of non-saccular shape (70.9%) and a male preponderance were noted.

Conclusion: Both braided stents were effective in the treatment of BA aneurysms, with good occlusion rates and favorable functional outcomes. Pipeline FD achieved a particularly higher aneurysm occlusion rate than LVIS stent at VBJ, where lesions often require reconstruction of the diseased vessel.

背景:低位可视腔内支撑(LVIS)支架和管道血流分流器(FDs)都是基底动脉(BA)动脉瘤的治疗策略,但还没有对它们进行直接比较:方法:对139例基底动脉瘤患者中的132例进行了分析。采用倾向评分匹配法(PSM)控制年龄、性别、高血压、动脉瘤大小、形状、位置和随访时间。比较了这两种编织支架的治疗效果:结果:88 例(63.3%)手术植入了 LVIS 支架,51 例(36.7%)手术植入了 Pipeline FD。Pipeline FDs患者多为年轻人,高血压较少,而动脉瘤患者的动脉瘤尺寸较大。在 PSM 后,使用 LVIS 支架和 Pipeline FDs 治疗的患者分别获得了相似的完全或接近完全闭塞率(76.7% vs 73.3%,p = .766)和良好的功能预后(86.7% vs 90.0%,p = 1)。在三个不同位置(基底动脉顶/基底动脉干/椎-基底动脉交界处 [VBJ])分别进行了进一步比较,结果显示,Pipeline FD 治疗后动脉瘤完全或接近完全闭塞率高于 LVIS 治疗(86.7% vs 59.2%,p = .012),仅在 VBJ,非圆形比例特别高(70.9%),且男性居多:结论:两种编织支架都能有效治疗BA动脉瘤,具有良好的闭塞率和良好的功能效果。在病变往往需要重建病变血管的VBJ,管道FD的动脉瘤闭塞率比LVIS支架更高。
{"title":"Treatment of basilar artery aneurysms with two braided stents: Two centers experience of low-profile visualized intraluminal support stents versus Pipeline flow diverters.","authors":"Bin Luo, Chao Wang, Jian Liu, Yisen Zhang, Kun Wang, Wenqiang Li, Ying Zhang","doi":"10.1177/19714009241242638","DOIUrl":"10.1177/19714009241242638","url":null,"abstract":"<p><strong>Background: </strong>Both low-profile visualized intraluminal support (LVIS)stents and Pipeline flow diverters (FDs) are therapeutic strategies for basilar artery (BA) aneurysms, but they have not been directly compared.</p><p><strong>Methods: </strong>A total of 132 consecutive patients with 139 BA aneurysms treated with either LVIS stent or Pipeline FDs were analyzed. Propensity score matching (PSM) was used to control for age, sex, hypertension, aneurysm size, shape, location, and duration of follow-up. The treatment results of these two braided stents were compared.</p><p><strong>Results: </strong>LVIS stent was placed in 88 (63.3%) and Pipeline FDs in 51 (36.7%) procedures. Patients with Pipeline FDs tended to be younger and have less hypertension, whereas aneurysms had larger aneurysm size. After PSM, similar complete or near-complete occlusion rates (76.7% vs 73.3%, <i>p</i> = .766) and favorable functional outcomes (86.7% vs 90.0%, <i>p</i> = 1) were achieved in patients treated with LVIS stents and Pipeline FDs, respectively. Further comparisons were conducted at three different locations (basilar apex/basilar trunk/vertebrobasilar artery junction [VBJ]) separately, and the results showed a higher complete or near-complete aneurysm occlusion rate after Pipeline FD treatment than LVIS treatment (86.7% vs 59.2%, <i>p</i> = .012) only at VBJ, where a particularly high proportion of non-saccular shape (70.9%) and a male preponderance were noted.</p><p><strong>Conclusion: </strong>Both braided stents were effective in the treatment of BA aneurysms, with good occlusion rates and favorable functional outcomes. Pipeline FD achieved a particularly higher aneurysm occlusion rate than LVIS stent at VBJ, where lesions often require reconstruction of the diseased vessel.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"500-509"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular treatment of acute arteriosclerotic vertebrobasilar occlusion: A single center experience. 急性动脉硬化性椎体-基底动脉闭塞的血管内治疗:单中心经验。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-01 Epub Date: 2024-04-01 DOI: 10.1177/19714009241242650
Daniele Morosetti, Alfredo Paolo Mascolo, Renato Argirò, Valerio Da Ros, Marco Nezzo, Sara Crociati, Gianluca Cecchi, Luca Funari, Marina Diomedi, Roberto Floris

Objectives: Few experiences on vertebrobasilar occlusion over underlying intracranial atherosclerotic disease have been reported in literature and the optimal strategy on how to perform a mechanical thrombectomy is unclear. The aim of this paper is to bring our experience based on patients admitted with acute vertebrobasilar occlusion with underlying atheromatous lesions.

Materials and methods: Several data were collected from August 2009 to October 2022 including clinical history, pre- and post-treatment neurological objectivity, diagnostic images and angiographic procedural images, and clinical outcome at 6 months. We selected 13 patients from August 2009 to October 2022, 12 men and 1 woman, aged 40 to 82 years (mean age, 62.6 years).

Results: Mechanical thrombectomy with a thromboaspiration was performed in all patients as beginning of the procedure. In three patients, the procedures resulted in excellent angiographic result and clinical outcome, while in three patients, we observed a failure of the procedural and clinical outcome. For residual intracranial stenosis in three patients, an angioplasty was performed obtaining an ischemic area related to the posterior circulation. In four patients, a stent was placed, in three patients, we obtained a good clinical outcome with a mRS between 0 and 2, while one treatment resulted in death, probably due to a late endovascular treatment.

Conclusions: Endovascular treatment with stent deployment appears to result in an excellent outcome in patients with occlusion of the vertebrobasilar circulation in cases of occlusion on atheromatic plaque. The degree of residual stenosis after thrombospiration can significantly affect subsequent type of treatment.

目的:关于椎-基底动脉闭塞伴有颅内动脉粥样硬化疾病的文献报道很少,如何进行机械性血栓切除术的最佳策略也不明确。本文旨在介绍我们对急性椎-基底动脉闭塞伴有潜在动脉粥样硬化病变患者的经验:从 2009 年 8 月到 2022 年 10 月,我们收集了一些数据,包括临床病史、治疗前后的神经客观情况、诊断图像和血管造影术图像,以及 6 个月的临床结果。我们选取了2009年8月至2022年10月期间的13名患者,其中男性12人,女性1人,年龄在40岁至82岁之间(平均年龄62.6岁):结果:所有患者在手术开始时都进行了机械血栓切除术和血栓抽吸术。三名患者的血管造影结果和临床疗效极佳,而三名患者的手术和临床疗效均不理想。针对三名患者的颅内残余狭窄,我们在与后循环相关的缺血区域进行了血管成形术。我们为四名患者植入了支架,其中三名患者的临床疗效良好,mRS介于0至2之间,而一名患者因血管内治疗过晚而死亡:结论:对于动脉粥样斑块闭塞的椎-基底动脉循环闭塞患者,通过支架置入进行血管内治疗似乎能取得很好的疗效。血栓形成后残余狭窄的程度会对后续治疗方式产生重大影响。
{"title":"Endovascular treatment of acute arteriosclerotic vertebrobasilar occlusion: A single center experience.","authors":"Daniele Morosetti, Alfredo Paolo Mascolo, Renato Argirò, Valerio Da Ros, Marco Nezzo, Sara Crociati, Gianluca Cecchi, Luca Funari, Marina Diomedi, Roberto Floris","doi":"10.1177/19714009241242650","DOIUrl":"10.1177/19714009241242650","url":null,"abstract":"<p><strong>Objectives: </strong>Few experiences on vertebrobasilar occlusion over underlying intracranial atherosclerotic disease have been reported in literature and the optimal strategy on how to perform a mechanical thrombectomy is unclear. The aim of this paper is to bring our experience based on patients admitted with acute vertebrobasilar occlusion with underlying atheromatous lesions.</p><p><strong>Materials and methods: </strong>Several data were collected from August 2009 to October 2022 including clinical history, pre- and post-treatment neurological objectivity, diagnostic images and angiographic procedural images, and clinical outcome at 6 months. We selected 13 patients from August 2009 to October 2022, 12 men and 1 woman, aged 40 to 82 years (mean age, 62.6 years).</p><p><strong>Results: </strong>Mechanical thrombectomy with a thromboaspiration was performed in all patients as beginning of the procedure. In three patients, the procedures resulted in excellent angiographic result and clinical outcome, while in three patients, we observed a failure of the procedural and clinical outcome. For residual intracranial stenosis in three patients, an angioplasty was performed obtaining an ischemic area related to the posterior circulation. In four patients, a stent was placed, in three patients, we obtained a good clinical outcome with a mRS between 0 and 2, while one treatment resulted in death, probably due to a late endovascular treatment.</p><p><strong>Conclusions: </strong>Endovascular treatment with stent deployment appears to result in an excellent outcome in patients with occlusion of the vertebrobasilar circulation in cases of occlusion on atheromatic plaque. The degree of residual stenosis after thrombospiration can significantly affect subsequent type of treatment.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"483-489"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atretic cephalocele and differential considerations: A small case series. 萎缩性头膨出与鉴别诊断:一个小病例系列。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-01 Epub Date: 2023-11-02 DOI: 10.1177/19714009231212367
Hallie Whalen, Sandrine Yazbek

Any posterior midline cystic or soft tissue scalp mass in an infant needs evaluation with MRI brain and MRV brain to look for intracranial extension of the lesion. One of the differential considerations is an atretic cephalocele, which can be a difficult diagnosis, especially when the cystic lesions are small. The presence of a small calvarial defect adjacent to the cystic mass and a persistent primitive falcine vein, which points towards the cystic mass, are imaging clues to this diagnosis. Correct diagnosis is needed prior to surgical resection to avoid potentially serious postoperative complications.

婴儿的任何后中线囊性或软组织头皮肿块都需要用MRI大脑和MRV大脑进行评估,以寻找病变的颅内扩展。其中一个区别考虑因素是闭锁性头膨出,这可能是一个困难的诊断,尤其是当囊性病变很小时。囊性肿块附近存在一个小的颅骨缺损,以及指向囊性肿块的持续原始镰状静脉,是这一诊断的影像学线索。手术切除前需要正确诊断,以避免潜在的严重术后并发症。
{"title":"Atretic cephalocele and differential considerations: A small case series.","authors":"Hallie Whalen, Sandrine Yazbek","doi":"10.1177/19714009231212367","DOIUrl":"10.1177/19714009231212367","url":null,"abstract":"<p><p>Any posterior midline cystic or soft tissue scalp mass in an infant needs evaluation with MRI brain and MRV brain to look for intracranial extension of the lesion. One of the differential considerations is an atretic cephalocele, which can be a difficult diagnosis, especially when the cystic lesions are small. The presence of a small calvarial defect adjacent to the cystic mass and a persistent primitive falcine vein, which points towards the cystic mass, are imaging clues to this diagnosis. Correct diagnosis is needed prior to surgical resection to avoid potentially serious postoperative complications.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"518-523"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statistical plots in oncologic imaging, a primer for neuroradiologists. 肿瘤成像中的统计图,神经放射医师入门指南。
IF 1.3 Q4 NEUROIMAGING Pub Date : 2024-08-01 Epub Date: 2023-08-02 DOI: 10.1177/19714009231193158
Sina Bagheri, Mohammad Taghvaei, Ariana Familiar, Debanjan Haldar, Alireza Zandifar, Nastaran Khalili, Arastoo Vossough, Ali Nabavizadeh

The simplest approach to convey the results of scientific analysis, which can include complex comparisons, is typically through the use of visual items, including figures and plots. These statistical plots play a critical role in scientific studies, making data more accessible, engaging, and informative. A growing number of visual representations have been utilized recently to graphically display the results of oncologic imaging, including radiomic and radiogenomic studies. Here, we review the applications, distinct properties, benefits, and drawbacks of various statistical plots. Furthermore, we provide neuroradiologists with a comprehensive understanding of how to use these plots to effectively communicate analytical results based on imaging data.

科学分析的结果可能包括复杂的比较,传达科学分析结果的最简单方法通常是使用可视化项目,包括数字和绘图。这些统计图表在科学研究中发挥着至关重要的作用,使数据更易于理解、更吸引人、信息量更大。近来,越来越多的可视化表示方法被用于以图形方式显示肿瘤成像结果,包括放射基因组学和放射基因组学研究。在此,我们回顾了各种统计图的应用、独特属性、优点和缺点。此外,我们还将让神经放射科医生全面了解如何使用这些图来有效传达基于成像数据的分析结果。
{"title":"Statistical plots in oncologic imaging, a primer for neuroradiologists.","authors":"Sina Bagheri, Mohammad Taghvaei, Ariana Familiar, Debanjan Haldar, Alireza Zandifar, Nastaran Khalili, Arastoo Vossough, Ali Nabavizadeh","doi":"10.1177/19714009231193158","DOIUrl":"10.1177/19714009231193158","url":null,"abstract":"<p><p>The simplest approach to convey the results of scientific analysis, which can include complex comparisons, is typically through the use of visual items, including figures and plots. These statistical plots play a critical role in scientific studies, making data more accessible, engaging, and informative. A growing number of visual representations have been utilized recently to graphically display the results of oncologic imaging, including radiomic and radiogenomic studies. Here, we review the applications, distinct properties, benefits, and drawbacks of various statistical plots. Furthermore, we provide neuroradiologists with a comprehensive understanding of how to use these plots to effectively communicate analytical results based on imaging data.</p>","PeriodicalId":47358,"journal":{"name":"Neuroradiology Journal","volume":" ","pages":"418-433"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9917209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neuroradiology Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1